The type III TGF-beta receptor suppresses breast cancer progression.
Dong M; How T; Kirkbride KC; Gordon KJ; Lee JD; Hempel N; Kelly P; Moeller BJ; Marks JR; Blobe GC; The Journal Of Clinical Investigation, 2007, vol. 117, issue 1, p 206, ISSN 00219738. ISBN 00219738.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef